Klaus-Peter Eisenwiener

Title: Klaus-Peter Eisenwiener: Innovator in Somatostatin Analogues

Introduction

Klaus-Peter Eisenwiener is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancerous diseases. With a total of 2 patents, his work focuses on innovative methods and compositions involving somatostatin analogues.

Latest Patents

Eisenwiener's latest patents include a treatment process using somatostatin analogues. This method characterizes a disease by an overexpression of one or more somatostatin receptors. It involves exposing these receptors to a pharmaceutical composition that includes a somatostatin analogue, which binds to the receptors. Another patent details compositions of somatostatin analogues, providing a general formula that includes various chelators and amino acids, enhancing the efficacy of the treatment.

Career Highlights

Eisenwiener is affiliated with the University of Bern, where he conducts research and develops his innovative ideas. His work has been instrumental in advancing the understanding and treatment of cancer through targeted therapies.

Collaborations

Eisenwiener collaborates with Helmut Robert Maecke, contributing to the advancement of their shared research interests.

Conclusion

Klaus-Peter Eisenwiener is a prominent figure in the field of pharmaceutical innovation, particularly in the development of somatostatin analogues for cancer treatment. His contributions continue to impact the medical community positively.